JPH051794B2 - - Google Patents

Info

Publication number
JPH051794B2
JPH051794B2 JP60295172A JP29517285A JPH051794B2 JP H051794 B2 JPH051794 B2 JP H051794B2 JP 60295172 A JP60295172 A JP 60295172A JP 29517285 A JP29517285 A JP 29517285A JP H051794 B2 JPH051794 B2 JP H051794B2
Authority
JP
Japan
Prior art keywords
compound
nmr
melting point
yellow powder
pale yellow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60295172A
Other languages
English (en)
Japanese (ja)
Other versions
JPS62155284A (ja
Inventor
Tadashi Hirata
Mitsuru Takahashi
Tsutomu Muragata
Hiroshi Kase
Koji Yamada
Kazuyuki Iwahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Priority to JP29517285A priority Critical patent/JPS62155284A/ja
Publication of JPS62155284A publication Critical patent/JPS62155284A/ja
Publication of JPH051794B2 publication Critical patent/JPH051794B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP29517285A 1985-12-27 1985-12-27 生理活性物質ｋ−２５２の誘導体 Granted JPS62155284A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP29517285A JPS62155284A (ja) 1985-12-27 1985-12-27 生理活性物質ｋ−２５２の誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29517285A JPS62155284A (ja) 1985-12-27 1985-12-27 生理活性物質ｋ−２５２の誘導体

Publications (2)

Publication Number Publication Date
JPS62155284A JPS62155284A (ja) 1987-07-10
JPH051794B2 true JPH051794B2 (enEXAMPLES) 1993-01-11

Family

ID=17817161

Family Applications (1)

Application Number Title Priority Date Filing Date
JP29517285A Granted JPS62155284A (ja) 1985-12-27 1985-12-27 生理活性物質ｋ−２５２の誘導体

Country Status (1)

Country Link
JP (1) JPS62155284A (enEXAMPLES)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0303697B1 (en) * 1987-03-09 1997-10-01 Kyowa Hakko Kogyo Co., Ltd. Derivatives of physiologically active substance k-252
JPH07113027B2 (ja) * 1987-12-24 1995-12-06 協和醗酵工業株式会社 Ｋ−２５２誘導体
US6271242B1 (en) 1992-02-10 2001-08-07 Bristol-Myers Squibb Co. Method for treating cancer using a tyrosine protein kinase inhibitor
US5621101A (en) * 1992-07-24 1997-04-15 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
US5461146A (en) * 1992-07-24 1995-10-24 Cephalon, Inc. Selected protein kinase inhibitors for the treatment of neurological disorders
US5756494A (en) * 1992-07-24 1998-05-26 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
JPH08500112A (ja) * 1992-08-12 1996-01-09 ジ・アップジョン・カンパニー タキソールと組み合わせるプロテインキナーゼ阻害剤および関連化合物
CA2123895A1 (en) * 1992-09-21 1994-03-31 Tatsuya Tamaoki A therapeutic agent for thrombocytopenia
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
EP0681475B1 (en) 1993-01-28 2010-10-27 Boston Scientific Limited Therapeutic inhibitors of vascular smooth muscle cells
EP0839814A3 (en) * 1993-05-28 1998-09-16 Cephalon, Inc. Indolocarbazole derivatives and their use for the treatment of prostate gland disorders
AU1911095A (en) * 1994-02-18 1995-09-04 Cephalon, Inc. Aqueous indolocarbazole solutions
US5585488A (en) * 1994-07-04 1996-12-17 Kyowa Hakko Kogyo Co., Ltd. Process for producing indolocarbazole derivatives
AU6714396A (en) * 1995-07-28 1997-02-26 Trustees Of Boston University Methods and compositions for treating cell proliferative disorders
US6875865B1 (en) 1996-06-03 2005-04-05 Cephalon, Inc. Selected derivatives of K-252a
UA67725C2 (en) 1996-06-03 2004-07-15 Cephalon Inc K-252a derivatives and a method for improvement of functioning and cell survival enhancement
PT912184E (pt) 1996-06-25 2002-12-31 Cephalon Inc Utilizacao de um derivado de k-252a para o tratamento de doencas do sietma nervoso central ou periferico e sobre-producao de citoquina
ES2388248T3 (es) 1997-03-31 2012-10-11 Boston Scientific Scimed Limited Forma de dosificación que comprende taxol en forma cristalina
US6093713A (en) 1997-12-31 2000-07-25 Kyowa, Hakko, Kogyo Co., Ltd. 3'-epimeric K-252A derivatives
US6200968B1 (en) 1998-08-06 2001-03-13 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
US7795246B2 (en) 1998-08-06 2010-09-14 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
US6472385B1 (en) 1999-08-09 2002-10-29 Trustees Of Darmouth College Compositions and methods to enhance cancer chemotherapy in p53 defective tumors
MX2007001155A (es) * 2004-07-29 2007-08-14 Creabilis Therapeutics Spa Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041489A (ja) * 1983-08-12 1985-03-05 Kyowa Hakko Kogyo Co Ltd 新規生理活性物質ｋ―２５２

Also Published As

Publication number Publication date
JPS62155284A (ja) 1987-07-10

Similar Documents

Publication Publication Date Title
JPH051794B2 (enEXAMPLES)
TWI833829B (zh) 聯苯類化合物，其中間體，製備方法，藥物組合物及應用
PL192354B1 (pl) Nowe pochodne izochinolino-3-karboksyamidów, sposób ich wytwarzania, zastosowanie tych pochodnych i środek farmaceutyczny
CZ174094A3 (en) Bicyclic compound having a core formed by two conjugated six-mebered rings and a pharmaceutical preparation containing thereof
JPS62155250A (ja) フエノキシアルキルカルボン酸およびエステル化合物，その製造方法および該化合物を含有する医薬組成物
JPS62155285A (ja) 生理活性物質ｋ−２５２の誘導体
US4243666A (en) 4-Amino-2-piperidino-quinazolines
RU2102392C1 (ru) Пиперидилметилзамещенные производные хромана и их соли с неорганическими кислотами
JPS63270678A (ja) 新規含窒素化合物
US4659733A (en) Method for treating hypertension with 2,3-diamino-1,4-butanedithiol; 4,5-diamino-1,2-dithiane; and N-acyl and N-alkyl derivatives thereof
CA2258539C (en) Ring-fused dihydropyranes, process for the preparation and use thereof
CN1037771C (zh) 甲氨喋呤衍生物
CN113402515B (zh) 一种吲哚类化合物及其制备方法和用途
JPS61218571A (ja) 新規ラクタム誘導体及び新規チオラクタム誘導体並びに抗炎症剤
KR102223885B1 (ko) 몰루긴 유도체 화합물, 및 이를 포함하는 염증성 장질환의 예방 또는 치료용 약학 조성물
CN102731296A (zh) 迷迭香酸衍生物及其制备方法与在制备抗结核药物中的应用
CA2012569A1 (en) Benzothiopyranylamines
US4160828A (en) Analgesic phosphinyl compounds and compositions
JPS63227570A (ja) イソキノリン誘導体
EP0602458A1 (en) 1,4-Benzoxazine derivatives
CN111303195B (zh) 一类含硼小分子化合物、其制备方法及应用
DK155280B (da) Analogifremgangsmaade til fremstilling af indolderivater
JPS62145073A (ja) キナゾリン査導体
JP3760484B2 (ja) チエノ［２，３−ｄ］ピリミジン−４−オン誘導体
FR2903698A1 (fr) Nouveaux derives de 5-thioxylopyranose.

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term